01 27INCYTE CORP
01 278822481
01 27Blank
01 27Blank
01 272028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3230
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1573
Delist Requested :
Patent Use Description : USE OF RUXOLITINIB (JA...
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3226
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3227
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3227
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3230
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1573
Delist Requested :
Patent Use Description : USE OF RUXOLITINIB (JA...
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8822481
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
